Intersect ENT, Inc., a leading innovator in the ear, nose, and throat (ENT) industry, is headquartered in the United States. Founded in 2011, the company has made significant strides in developing advanced solutions for chronic sinusitis and other ENT conditions. With a focus on minimally invasive procedures, Intersect ENT's core products, including the Propel® and Sinuva® implants, are designed to improve patient outcomes and enhance recovery. The company has established a strong market position, recognised for its commitment to innovation and patient care. Intersect ENT's unique offerings not only address the needs of healthcare providers but also prioritise patient comfort and satisfaction. As a key player in the ENT space, Intersect ENT continues to shape the future of sinus care with its cutting-edge technologies and dedication to improving quality of life for patients.
We don't have data for Intersect ENT, Inc., but we can show you information about their parent organization instead.
View parent company